X. Xu

发表

Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples.

T. Eley, X. Xu, A. Rose, 2014, Bioanalysis.

Simultaneous oral therapeutic and intravenous ¹⁴C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin.

F. LaCreta, D. Boulton, S. Kasichayanula, 2013, British journal of clinical pharmacology.

Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.

Jim X. Shen, W. Humphreys, S. Dueker, 2012, Bioanalysis.

Sensitivity-based analytical approaches to support human absolute bioavailability studies.

Jim X. Shen, Hao Jiang, X. Xu, 2014, Bioanalysis.

The protein S-nitrosylation of splicing and translational machinery in vascular endothelial cells is susceptible to oxidative stress induced by oxidized low-density lipoprotein.

Lan Jin, L. Chi, Qunye Zhang, 2019, Journal of proteomics.

Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations.

W. Humphreys, M. Kirby, D. Boulton, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Quantitative determination of a novel dual PPAR α/γ agonist using on-line turbulent flow extraction with liquid chromatography-tandem mass spectrometry

X. Xu, M. Lo, K. Yan, 2005 .

Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption

L. Benet, L. Frassetto, Hsin-Fang Wu, 2016, Pharmaceutical Research.

A Randomized Trial in Healthy Subjects to Assess the Bioequivalence of an Atazanavir/Cobicistat Fixed-Dose Combination Tablet versus Administration as Separate Agents

P. Ravindran, R. Bertz, X. Xu, 2015, Antiviral therapy.

Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir.

R. Bertz, Yaoshi Wu, Jenny Zhang, 2011, The Journal of antimicrobial chemotherapy.

Selective reaction monitoring of negative electrospray ionization acetate adduct ions for the bioanalysis of dapagliflozin in clinical studies.

Jim X. Shen, D. Boulton, Jane Liu, 2015, Analytical chemistry.

Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma.

M. Tirmenstein, J. Cai, Yuzhong Deng, 2010, Bioanalysis.

Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.

R. Linhardt, Lan Jin, Xinyue Liu, 2016, Journal of pharmaceutical sciences.

Mass spectrometry following mild enzymatic digestion reveals phosphorylation of recombinant proteins in Escherichia coli through mechanisms involving direct nucleotide binding.

K. Standing, Z. Jia, L. Donald, 2010, Journal of proteome research.

Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants

D. Seiffert, Zhaoqing Wang, T. Ueno, 2022, Scientific Reports.

Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC-MS/MS: application to pharmacokinetic interaction study.

X. Xu, Tian Feng, Nan Zhou, 2020, Bioanalysis.

Mixed micelle as nanocarrier for etomidate: Development, in vitro characterizations, and in vivo study on toxicity and anesthetic effects

Xue-Yun Zhou, X. Xu, Hao Liu, 2019, Journal of Drug Delivery Science and Technology.

MEKC DETERMINATION OF GUAIFENESIN, PSEUDOEPHEDRINE, AND DEXTROMETHORPHAN IN A CAPSULE DOSAGE FORM

J. T. Stewart, X. Xu, James T. Stewart, 2000 .

Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.

M. Krystal, R. Bertz, A. Persson, 2012, The Journal of antimicrobial chemotherapy.

CYP2C19 Genotype–Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir‐Boosted Atazanavir in Healthy Subjects

Li Zhu, R. Bertz, Jonathan Uy, 2017, Journal of clinical pharmacology.

Effect of Low‐Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple‐Dose Atazanavir With Ritonavir in Healthy Subjects

R. Bertz, A. Persson, T. Eley, 2011, Journal of clinical pharmacology.

The Effect of Atazanavir/Ritonavir on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Women

R. Bertz, A. Persson, T. Eley, 2011, Antiviral therapy.

Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies

T. Eley, X. Xu, L. Zaru, 2017, The Pediatric infectious disease journal.

Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.

Lianli Chi, Lequan Chi, Lan Jin, 2014, Carbohydrate polymers.

Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.

Lianli Chi, Lequan Chi, Xiaohui Xu, 2015, Carbohydrate research.

Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studies.

Carol Gleason, Xiaohui Xu, Mohammed Jemal, 2013, Bioanalysis.

Bioanalytical challenges and unique considerations to support pharmacokinetic characterization of bispecific biotherapeutics.

Sheldon S. Leung, S. Pederson, M. Ma, 2019, Bioanalysis.

Quantitative determination of a novel dual PPAR alpha/gamma agonist using on-line turbulent flow extraction with liquid chromatography-tandem mass spectrometry.

Hengchang Song, Man-Wai Lo, Xiaohui Sophia Xu, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.